We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Azenta Inc (AZTA) USD0.01

Sell:$53.77 Buy:$53.84 Change: $1.59 (2.88%)
Market closed |  Prices as at close on 18 July 2024 | Switch to live prices |
Change: $1.59 (2.88%)
Market closed |  Prices as at close on 18 July 2024 | Switch to live prices |
Change: $1.59 (2.88%)
Market closed |  Prices as at close on 18 July 2024 | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

Azenta, Inc. is a provider of biological and chemical compound sample exploration and management solutions for the life sciences industry. The Company’s segments include Sample Management Solutions, Multiomics and B Medical Systems. The Sample Management Solutions segment offers end-to-end sample management products and services, including sample and repository services and core products (automated stores, cryogenic systems, automated sample tube, and consumables and instruments). The Multiomics segment provides genomic and other sample analysis services, including gene sequencing and gene synthesis. B Medical Systems segment is focused on the manufacturing and distribution of temperature-controlled storage and transportation solutions in international markets to governments, health institutions, and non-government organizations. It provides products and services through its brands, including GENEWIZ, FluidX, Ziath, 4titude, Limfinity, Freezer Pro, Barkey, and B Medical Systems.

Contact details

200 Summit Drive, 6Th Floor
United States
+1 (978) 2622400

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
Market cap:
$3.08 billion
Shares in issue:
53.92 million
Life Sciences Tools & Services
United States
US dollar
NASDAQ Comb. Composite

Key personnel

  • Stephen Schwartz
    President, Chief Executive Officer
  • Herman Cueto
    Chief Financial Officer, Executive Vice President
  • Olga Pirogova
    Chief Human Resource Officer, Senior Vice President
  • Jason Joseph
    Senior Vice President, General Counsel, Secretary
  • Ginger Zhou
    Senior Vice President, General Manager - Genomic Services
  • David Gray
    Senior Vice President, Chief Strategy and New Business Officer
  • Robin Vacha
    Senior Vice President - Global Operations
  • David Wang
    Senior Vice President and General Manager, Sample Management Solutions
  • Violetta Hughes
    Chief Accounting Officer, Vice President and Principal Accounting Officer

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.


The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.